NovoRapid FlexPen 100 U/mL is a rapid-acting Insulin Aspart injection developed by Novo Nordisk for precise and fast glucose control. Designed for convenient pre-meal dosing, it closely mimics the body’s natural insulin response after eating, helping maintain optimal blood sugar levels throughout the day.
 
Key Benefits
✔ Rapid onset of action within 10–20 minutes after injection.
✔ Provides better post-meal glucose control compared to regular human insulin.
✔ Predictable absorption and consistent effect for reliable daily management.
✔ Easy-to-use prefilled FlexPen ensures accurate dosing and minimal injection discomfort.
✔ Suitable for combination therapy with long-acting basal insulins.
✔ Manufactured by Novo Nordisk, globally trusted for insulin quality and safety.
 
 
Product Specifications
Product: NovoRapid FlexPen
Molecule: Insulin Aspart
Potency: 100 U/mL
Appearance: Clear, colorless injectable solution in prefilled pen
Dosage: Inject subcutaneously immediately before meals or as directed by a healthcare professional
Packing: Box of 5 prefilled pens
 
How It Works
NovoRapid (Insulin Aspart) is a rapid-acting insulin analogue designed to replicate the body’s natural insulin surge after food intake. It promotes glucose uptake into cells and suppresses hepatic glucose production, helping prevent postprandial hyperglycemia. Its fast onset and short duration make it ideal for flexible meal-time insulin management.
 
 
Who Is It For?
✅ Adults and children with Type 1 or Type 2 diabetes requiring mealtime insulin coverage
✅ Healthcare professionals managing intensive insulin therapy
✅ Patients seeking fast-acting insulin for better meal-time glucose control
✅ Endocrinologists and diabetologists optimizing postprandial glycemic balance
 
keywords: insulin คือ, insulin syringes, nph ยา, ยา insulin, insulin ยา, novorapid penfill, insulin pen, novorapid flexpen, novorapid insulin, NovoRapid ราคา, Cost of insulin in Thailand